Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for tachycardia in septic ICU patients
ACTRN12616000940471Phase 2Recruiting
- Sponsor
- A/Prof Andrew Udy,
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ivabradine in sepsis, sponsored by A/Prof Andrew Udy,. Primary endpoint: Heart rate. Started Mar 2016; status: recruiting.
02
Drugs
ivabradine
03
Conditions
sepsis
Beyond the preview
Go deeper on ACTRN12616000940471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000940471.